Related changes

Jump to navigation Jump to search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 11:06, 29 March 2024
   
Page name:
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

28 March 2024

 m   16:00  Waldenström macroglobulinemia‎‎ 2 changes history +311 [Jwarner‎ (2×)]
 m   
16:00 (cur | prev) +312 Jwarner talk contribs →‎BDR {{#subobject:2529c7|Regimen=1}}
 m   
15:36 (cur | prev) -1 Jwarner talk contribs

27 March 2024

 m   00:27  Acute promyelocytic leukemia‎‎ 2 changes history -40 [Warner-admin‎ (2×)]
 m   
00:27 (cur | prev) -32 Warner-admin talk contribs Text replacement - "One course of up to 90 days" to "Up to 90-day course"
 m   
00:27 (cur | prev) -8 Warner-admin talk contribs Text replacement - "One course of up to 60 days" to "Up to 60-day course"

26 March 2024

 m   01:35  Acute promyelocytic leukemia diffhist +5 Jwarner talk contribs →‎Targeted therapy

23 March 2024

 m   12:25  B-cell acute lymphoblastic leukemia‎‎ 3 changes history -54 [Jwarner‎ (3×)]
 m   
12:25 (cur | prev) +2,810 Jwarner talk contribs →‎Relapsed or refractory
 m   
12:25 (cur | prev) -2,834 Jwarner talk contribs →‎Cytarabine & Mitoxantrone (MC) {{#subobject:6237f0|Regimen=1}}
 m   
12:25 (cur | prev) -30 Jwarner talk contribs →‎Inotuzumab ozogamicin monotherapy {{#subobject:d90806|Regimen=1}}